NPS Pharmaceuticals (NPSP) Names Dr. Tony Coles As CEO
Tweet Send to a FriendGet Alerts NPSP Hot Sheet
Down)
Trade NPSP Now!
NPS Pharmaceuticals (Nasdaq: NPSP) announced that its board of directors has named company COO and president Dr. Tony Coles as its chief executive officer, succeeding Dr. Hunter Jackson who stepped down as NPS chairman and CEO.
Dr. Coles joined NPS in November 2005 as part of a planned transition, following Dr. Jackson's announcement that he would step down as chairman and CEO. Dr. Coles was appointed to his new post yesterday during the board of directors meeting in Parsippany, NJ. Dr. Jackson will remain on the NPS board of directors.
Dr. Coles joined NPS in November 2005 as part of a planned transition, following Dr. Jackson's announcement that he would step down as chairman and CEO. Dr. Coles was appointed to his new post yesterday during the board of directors meeting in Parsippany, NJ. Dr. Jackson will remain on the NPS board of directors.
You May Also Be Interested In
- NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year® 2013
- U.S. SEC Appoints Lona Nallengara as Chief of Staff; Keith Higgins as Corp. Finance Director
- Delta Air Lines (DAL) Higher, President Sees 'Very, Very Strong' Second Quarter
Create E-mail Alert Related Categories
Management Changes
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
